SILVER SPRING, Md. Nov 2 (Reuters) - US health advisers on Wednesday put some weight behind Merck & Co's cholesterol-lowering drug Vytorin in preventing stroke and other heart problems in patients with chronic kidney disease. ... US advisers back Vytorin in some kidney patients
Tuesday, November 1, 2011
US advisers back Vytorin in some kidney patients
SILVER SPRING, Md. Nov 2 (Reuters) - US health advisers on Wednesday put some weight behind Merck & Co's cholesterol-lowering drug Vytorin in preventing stroke and other heart problems in patients with chronic kidney disease. ... US advisers back Vytorin in some kidney patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment